Albemarle Corporation

Equities

ALB

US0126531013

Specialty Chemicals

Market Closed - Nyse 04:00:02 2024-03-27 pm EDT Pre-market 08:06:52 am
128.8 USD +8.23% Intraday chart for Albemarle Corporation 128.5 -0.25%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Chile opens lithium salt flats for investment, saves two for state control RE
America's lithium laws fail to keep pace with rapid development RE
Australia's MinRes to develop a lithium processing hub in Goldfields region RE
Albemarle to auction lithium as part of push for price transparency RE
Teck Resources mulls British Columbia battery recycling plant RE
Albemarle's Recent Convertible Equity Raise 'Expensive,' Morgan Stanley Says MT
Morgan Stanley Cuts Price Target on Albemarle to $81 From $90 to Account for Net Dilution From Share Offering; Underweight Kept MT
Mizuho Securities Cuts Price Target on Albemarle to $112 From $115, Maintains Neutral Rating MT
KeyBanc Adjusts Price Target on Albemarle to $159 From $178, Maintains Overweight Rating MT
Albemarle Rises After Pricing of Upsized Offering of Depositary Shares MT
Albemarle Prices Upsized Offering of Depositary Shares MT
Equity Markets Fall as Apple, Others Weigh on Tech MT
Top Midday Decliners MT
US Equity Indexes Fall, Treasury Yields Lower After ISM Services Index Drops MT
US Benchmark Indexes Drop With Treasury Yields as ISM Services Index Declines More Than Forecast MT
Global markets live: Bayer, Target, Gitlab, Tesla, Amazon... Our Logo
Tesla, Apple and China’s delusions Our Logo
Albemarle Launches $1.75 Billion Offering of Depositary Shares; Stock Down After-Hours MT
Yellen sees big jump in US imports from Chile, eyes progress on green transition RE
Chile wants 3 or 4 new lithium projects running in 2026, finance minister says RE
Yellen: critical minerals sales to boost US imports from Chile 'substantially' RE
Chile's SQM expects steady lithium prices in coming months amid supply glut RE
Mizuho Securities Raises Price Target on Albemarle to $115 From $105, Maintains Neutral Rating MT
Transcript : Albemarle Corporation Presents at BMO 33rd Global Metals, Mining & Critical Minerals Conference 2024, Feb-26-2024 01:30 PM
ANALYST RECOMMENDATIONS : AbbVie, Doordash, Eli Lilly, Moderna, Hiscox... Our Logo
Chart Albemarle Corporation
More charts
Albemarle Corporation is one of the world's leading manufacturers of specialty chemicals. The group's products are aimed primarily at the petroleum refining, energy storage, consumer electronics, construction, crop protection, automotive, food safety and pharmaceuticals industries. Net sales break down by family of products as follows: - lithium and polymer solutions (73.6%); - bromine (15.4%); - catalysts (11%). Exports account for 90.3% of net sales.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
128.8 USD
Average target price
150 USD
Spread / Average Target
+16.48%
Consensus
  1. Stock
  2. Equities
  3. Stock Albemarle Corporation - Nyse
  4. News Albemarle Corporation
  5. Wells Fargo Adjusts Albemarle's Price Target to $215 From $260, Maintains Equalweight Rating